Clinical Trials Directory

Trials / Completed

CompletedNCT03102515

Transversus Abdominis Plane Block vs Continuous Infiltration Wound Catheter for Analgesia After Caesarean Section

Transversus Abdominis Plane Block vs Continuous Infiltration Wound Catheter for Analgesia After Caesarean Section: a Randomized Trial. (TAP-CAT Study)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
109 (actual)
Sponsor
University Hospital, Caen · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Analgesia following surgery associates different intra-venous or oral analgesic drugs and sometimes opioids. To reduce opioid consumption, loco-regional anaesthesia might be administered as a complement. In the specific context of caesarean sections, pain control is mandatory to enable the mother to take care of her offspring and shorten their hospital stay. This intervention is mainly performed under neuraxial anaesthesia (spinal or epidural), enabling the injection of morphine in the subdural or epidural space, as part of a multimodal analgesia regimen. Studies have evaluated continuous wound infiltration catheters (CIC) and ultrasound-guided (UGD) transabdominis plane (TAP) block, and both techniques and both techniques reduce postoperative morphine consumption. Recent studies have compared the two techniques and found conflicting results. Furthermore, they did not consider caesarean section performed under epidural analgesia, with a different neuraxial injection site, neither did they compared pain after postoperative day 2. Consequently, the aim of this study was to compare resting and standing pain up to postoperative day 3 after caesarean section performed under spinal or epidural anaesthesia and receiving either USG-TAP block or CIC. Baseline hypothesis was that the continuous infiltration provided a better analgesia at day 2.

Conditions

Interventions

TypeNameDescription
DRUGUSG-TAP block
DRUGCIC

Timeline

Start date
2016-05-29
Primary completion
2016-10-26
Completion
2016-10-26
First posted
2017-04-05
Last updated
2020-09-01

Source: ClinicalTrials.gov record NCT03102515. Inclusion in this directory is not an endorsement.